Ua hōʻike nā poʻe maʻi niumonia COVID-19 i ka hoʻomaikaʻi nui ʻana ma hope o ka mālama ʻana me ka laser ma ka haukapila nui o Massachusetts

Ua hōʻike ʻia kahi ʻatikala i paʻi ʻia ma ka American Journal of Case Reports i ka hiki o ka mālama ʻana i ka photobiomodulation therapy no nā poʻe maʻi me COVID-19.
LOWELL, MA, ʻAukake 9, 2020 /PRNewswire/ — Ua hōʻike ʻo Kauka Scott Sigman, ka mea noiʻi alakaʻi a me ka mea kākau alakaʻi, i nā hopena maikaʻi mai ka hoʻohana mua ʻana o ka laser therapy e mālama i kahi maʻi me ka maʻi pneumonia COVID-19. Ua hōʻike ʻia kahi ʻatikala i paʻi ʻia ma ka American Journal of Case Reports ma hope o ka mālama ʻana me ke kōkua me ka photobiomodulation therapy (PBMT), ua hoʻomaikaʻi ʻia ka helu hanu o ka mea maʻi, nā ʻike radiographic, ke koi oxygen, a me ka hopena i loko o nā lā me ka ʻole o ka pono no ka ventilator. 1 Ua komo nā mea maʻi i hoʻokomo ʻia i loko o kēia hōʻike i kahi hoʻokolohua lapaʻau randomized o 10 mau maʻi me ka COVID-19 i hōʻoia ʻia.
ʻO ka mea maʻi, he ʻApelika ʻAmelika 57 makahiki i ʻike ʻia me SARS-CoV-2, ua hoʻokomo ʻia i loko o ka hale mālama koʻikoʻi me ka maʻi hanu ʻeha a pono i ka oxygen. Ua hana ʻo ia i ʻehā mau kau PBMT 28-minuke i kēlā me kēia lā me ka hoʻohana ʻana i kahi mea hoʻōla laser Multiwave Locking System (MLS) i ʻāpono ʻia e ka FDA (ASA Laser, Italia). ʻO ka laser lapaʻau MLS i hoʻohana ʻia ma kēia haʻawina ua hoʻolaha wale ʻia ma ʻAmelika ʻĀkau e Cutting Edge Laser Technologies o Rochester, NY. Ua loiloi ʻia ka pane a ka mea maʻi i ka PBMT ma ka hoʻohālikelike ʻana i nā mea hana loiloi like ʻole ma mua a ma hope o ka mālama ʻana i ka laser, a ua hoʻomaikaʻi ʻia nā mea a pau ma hope o ka mālama ʻana. Hōʻike nā hopena:
Ma mua o ka mālama ʻana, ua moe ka mea maʻi ma kahi moe ma muli o ka ʻū nui a ʻaʻole hiki ke neʻe. Ma hope o ka mālama ʻana, ua nalowale nā ​​​​hōʻailona ʻū o ka mea maʻi, a ua hiki iā ia ke iho i lalo me ke kōkua o nā hoʻomaʻamaʻa physiotherapy. I kekahi lā aʻe, ua hoʻokuʻu ʻia ʻo ia i kahi kikowaena hoʻōla hou me ke kākoʻo oxygen liʻiliʻi. Ma hope o hoʻokahi lā wale nō, ua hiki i ka mea maʻi ke hoʻopau i ʻelua mau hoʻokolohua o ka piʻi ʻana i ke alapiʻi me ka physiotherapy a ua hoʻoneʻe ʻia i ka ea lumi. I ka hahai ʻana, ua mau kona hoʻōla lapaʻau he ʻekolu pule, me ka manawa waena he ʻeono a ʻewalu pule.
"Ua hōʻoia ʻia ka lāʻau lapaʻau photobiomodulation hou aʻe he pono i ka mālama ʻana i nā hōʻailona hanu i nā hihia koʻikoʻi o ka pneumonia i hoʻokumu ʻia e COVID-19. Manaʻo mākou he koho mālama kūpono kēia koho lapaʻau," wahi a Kauka Sigman. "Aia kahi pono olakino e hoʻomau nei no nā koho lapaʻau palekana a ʻoi aku ka maikaʻi no COVID-19. Manaʻolana mākou e paipai kēia hōʻike a me nā haʻawina ma hope aku i nā poʻe ʻē aʻe e noʻonoʻo i nā hoʻokolohua lapaʻau hou e hoʻohana ana i ka adjuvant PBMT no ka mālama ʻana i ka pneumonia COVID-19."
Ma PBMT, hoʻomālamalama ʻia ke kukui e nā ʻiʻo i hōʻino ʻia a hoʻopili ʻia ka ikehu kukui e nā cell, kahi e hoʻomaka ai i kahi moʻo o nā hopena molekala e hoʻomaikaʻi i ka hana cellular a wikiwiki i ke kaʻina hana ho'ōla o ke kino. Ua hōʻoia ʻo PBMT i nā waiwai anti-inflammatory a ke puka mai nei ma ke ʻano he ʻano hana ʻē aʻe no ka hōʻoluʻolu ʻeha, ka mālama ʻana i ka lymphedema, ka ho'ōla ʻana i nā ʻeha a me nā ʻeha musculoskeletal. ʻO ka hoʻohana ʻana i ka mālama PBMT e mālama ai iā COVID-19 e pili ana i ke kumumanaʻo e hiki aku ke kukui laser i ka ʻiʻo māmā e hōʻemi i ka mumū a hoʻolaha i ka ho'ōla. Eia kekahi, ʻaʻole invasive ka PBMT, kūpono ke kumukūʻai, a ʻaʻohe hopena ʻaoʻao i ʻike ʻia.
Hoʻohana ka laser MLS i kahi scanner kelepona me 2 mau diode laser synchronized, hoʻokahi pulsed (hoʻololi ʻia mai 1 a 2000 Hz) e hoʻopuka ana ma 905 nm a ʻo kekahi pulsed ma 808 nm. Hana like nā nalu laser ʻelua a ua synchronized. Hoʻonoho ʻia ka laser he 20 cm ma luna o ka mea maʻi e moe ana, ma waena o ke kahua māmā. ʻAʻohe ʻeha o nā lasers a ʻaʻole ʻike pinepine nā mea maʻi e hana ʻia ana ka mālama ʻana o ka laser. Hoʻohana pinepine ʻia kēia laser ma nā ʻiʻo hohonu e like me nā hui ʻūhā a me nā pelvic, i hoʻopuni ʻia e nā ʻiʻo mānoanoa. ʻO ka nui therapeutic i hoʻohana ʻia e hoʻokō i nā pahuhopu pelvic hohonu he 4.5 J/cm2. Ua helu ka mea kākau pū o ke aʻo ʻana ʻo Kauka Soheila Mokmeli ua hoʻopili ʻia he 7.2 J/cm2 i ka ʻili, e hāʻawi ana i kahi nui therapeutic o ka ikehu laser ma luna o 0.01 J/cm2 i nā māmā. Hiki i kēia nui ke komo i loko o ka paia umauma a hiki i ka ʻiʻo māmā, e hana ana i kahi hopena anti-inflammatory e hiki ke pale i nā hopena o ka ʻino cytokine i ka pneumonia COVID-19. No ka ʻike hou aku e pili ana i ka mālama ʻana i ka laser MLS, e ʻoluʻolu e leka uila iā Mark Mollenkopf [email protected] a i ʻole e kelepona i ka 800-889-4184 ext. 102.
No ka ʻike hou aku e pili ana i kēia hana mua a me ka papahana noiʻi, e ʻoluʻolu e kelepona iā Scott A. Sigman, MD ma [email protected] a i ʻole e kelepona iā 978-856-7676.
1 Sigman SA, Mokmeli S., Monich M., Vetrichi MA (2020). He kāne ʻApelika ʻAmelika 57 makahiki me ka maʻi pneumonia COVID-19 koʻikoʻi e pane ana i ka lāʻau lapaʻau photobiomodulation kākoʻo (PBMT): ka hoʻohana mua ʻana o PBMT no COVID-19. Am J Case Rep 2020; 21:e926779. DOI: 10.12659/AJCR.926779